Robot | Path | Permission |
GoogleBot | / | ✔ |
BingBot | / | ✔ |
BaiduSpider | / | ✔ |
YandexBot | / | ✔ |
Title | Home - Rezolute |
Description | Our Virtual Kol Event: RZ402 - An Oral Plasma Kallikrein Inhibitor for DME - Wednesday, March 22, 2023 at 4:30 PM Edt Learn More » --> Investors & Me |
Keywords | N/A |
WebSite | rezolutebio.com |
Host IP | 174.129.30.187 |
Location | United States |
Site | Rank |
US$8,458,321
Last updated: 2023-04-29 10:43:31
rezolutebio.com has Semrush global rank of 1,251,348. rezolutebio.com has an estimated worth of US$ 8,458,321, based on its estimated Ads revenue. rezolutebio.com receives approximately 975,961 unique visitors each day. Its web server is located in United States, with IP address 174.129.30.187. According to SiteAdvisor, rezolutebio.com is safe to visit. |
Purchase/Sale Value | US$8,458,321 |
Daily Ads Revenue | US$7,808 |
Monthly Ads Revenue | US$234,231 |
Yearly Ads Revenue | US$2,810,766 |
Daily Unique Visitors | 65,065 |
Note: All traffic and earnings values are estimates. |
Host | Type | TTL | Data |
rezolutebio.com. | A | 600 | IP: 174.129.30.187 |
rezolutebio.com. | A | 600 | IP: 54.208.101.55 |
rezolutebio.com. | NS | 3600 | NS Record: ns03.domaincontrol.com. |
rezolutebio.com. | NS | 3600 | NS Record: ns04.domaincontrol.com. |
rezolutebio.com. | MX | 3600 | MX Record: 0 rezolutebio-com.mail.protection.outlook.com. |
rezolutebio.com. | TXT | 3600 | TXT Record: v=spf1 include:spf.protection.outlook.com -all |
Virtual Kol Event: RZ402 - An Oral Plasma Kallikrein Inhibitor for DME - Wednesday, March 22, 2023 at 4:30 PM Edt Learn More » --> Investors & Media Overview Corporate Presentation News & Events Stock Quote and Chart Historical Data Analyst Coverage SEC Filings Governance Info Contact Us Therapeutic Focus Pipeline RZ358 RZ402 Publications Data Presentations For Patients Overview Living with HI Living with DME About Our Mission Leadership Board of Directors Scientific Advisory Board Join Us Our Mission Open Positions Benefits Contact Us Investors & Media Overview Corporate Presentation News & Events Stock Quote and Chart Historical Data Analyst Coverage SEC Filings Governance Info --> Elevating the Standard of Care with Transformative Therapies Our Mission Rezolute is a clinical stage biopharmaceutical company dedicated to developing transformative therapies for patients suffering from debilitating metabolic diseases. Ready to Join Us? » Disease Focus Congenital |
HTTP/1.1 301 Moved Permanently Date: Fri, 22 Oct 2021 09:01:49 GMT Server: Apache Location: http://www.rezolutebio.com/ Content-Type: text/html; charset=UTF-8 HTTP/1.1 302 Moved Temporarily Content-Type: text/html; charset=UTF-8 Date: Fri, 22 Oct 2021 09:01:49 GMT Location: https://www.rezolutebio.com/ Server: Apache Connection: keep-alive HTTP/1.1 200 OK Date: Fri, 22 Oct 2021 09:01:49 GMT Server: Apache X-Frame-Options: SAMEORIGIN Content-Type: text/html; charset=UTF-8 |
Domain Name: REZOLUTEBIO.COM Registry Domain ID: 2176173409_DOMAIN_COM-VRSN Registrar WHOIS Server: whois.godaddy.com Registrar URL: http://www.godaddy.com Updated Date: 2019-10-18T14:44:53Z Creation Date: 2017-10-18T19:10:06Z Registry Expiry Date: 2021-10-18T19:10:06Z Registrar: GoDaddy.com, LLC Registrar IANA ID: 146 Registrar Abuse Contact Email: abuse@godaddy.com Registrar Abuse Contact Phone: 480-624-2505 Domain Status: clientDeleteProhibited https://icann.org/epp#clientDeleteProhibited Domain Status: clientRenewProhibited https://icann.org/epp#clientRenewProhibited Domain Status: clientTransferProhibited https://icann.org/epp#clientTransferProhibited Domain Status: clientUpdateProhibited https://icann.org/epp#clientUpdateProhibited Name Server: NS03.DOMAINCONTROL.COM Name Server: NS04.DOMAINCONTROL.COM DNSSEC: unsigned >>> Last update of whois database: 2021-09-11T00:31:32Z <<< |